US STOCK
CORT Stock Analysis
US stocks · market data · technical indicators
Corcept Therapeutics Incorporated
CORTUS stocksQuote delayed 15 min
10/27 上午02:43 updated
$86.17
+0.31+0.36%
Open
$86.10
High
$91.78
Low
$85.86
Volume
114.87萬
CORT price history
-25.36%Open
115.63
Latest
86.31
High
122.03
Low
85.86
Average
113.33
Advertisement
Financial snapshot
CORT - Corcept Therapeutics Incorporated
EPS
0.45USD
Forward EPS
4.20USD
P/E
191.74x
Forward P/E
20.56x
P/B
13.19x
ROE
8.23%
ROA
0.47%
Operating margin
16.12%
Profit margin
6.64%
Revenue growth
31.70%
Earnings growth
24.10%
Dividend yield
0.00%
Financial statements
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| Revenue | $256.15M | $164.90M | $202.13M | $207.64M | $194.43M |
| Gross profit | $252.09M | $162.02M | $199.58M | $203.04M | $191.00M |
| Operating income | $41.30M | -$49.60M | $4.49M | $10.22M | $26.68M |
| Net income | $42.99M | -$31.76M | $24.29M | $19.67M | $35.15M |
| Basic EPS | 0.40 | -0.30 | 0.23 | 0.19 | 0.33 |
| Diluted EPS | 0.36 | -0.30 | 0.20 | 0.16 | 0.29 |
Estimates vs actuals
Next earnings
2026-11-04
EPS estimate
0.84
Revenue estimate
$336.37M
Last surprise
+535.26%
| Date | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-11-04 | 0.84 | Not reported | — |
| 2026-07-29 | 0.06 | 0.36 | +535.26% |
| 2026-04-30 | -0.14 | -0.30 | -111.27% |
| 2026-02-24 | 0.33 | 0.20 | -39.39% |
| 2025-11-04 | 0.14 | 0.16 | +18.52% |
| 2025-07-31 | 0.19 | 0.29 | +54.67% |
| 2025-05-05 | 0.14 | 0.17 | +19.30% |
| 2025-02-26 | 0.42 | 0.26 | -38.58% |
| 2024-10-30 | 0.29 | 0.41 | +41.38% |
| 2024-07-29 | 0.24 | 0.32 | +34.74% |
| 2024-05-01 | 0.22 | 0.25 | +13.64% |
| 2024-02-15 | 0.27 | 0.28 | +3.70% |
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| BlackRock Inc. | 2024-06-30 | $537.4M | 0.01% |
| RENAISSANCE TECHNOLOGIES LLC | 2026-06-30 | $457.5M | 0.63% |
| VANGUARD GROUP INC | 2025-12-31 | $330.4M | 0.00% |
| STATE STREET CORP | 2026-06-30 | $285.2M | 0.01% |
| TWO SIGMA INVESTMENTS, LP | 2026-06-30 | $53M | 0.04% |
| CITADEL ADVISORS LLC | 2026-06-30 | $9.5M | 0.00% |
| Bridgewater Associates, LP | 2026-06-30 | $5M | 0.02% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$141.00
Target range
$50.00 – $165.00
Implied upside
63.41%
Strong buy
1
Buy
3
Hold
0
Sell
1
Strong sell
0
Advertisement